1. The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemia. Issue 2 (3rd April 2018) Authors: Block, Geoffrey A; Rosenbaum, David P; Yan, Andrew; Greasley, Peter J; Chertow, Glenn M; Wolf, Myles Journal: Nephrology dialysis transplantation Issue: Volume 34:Issue 2(2019) Page Start: 339 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The relationship between the proportion of admitted high risk ACS patients and hospital delivery of evidence based care. (1st November 2016) Authors: Brieger, David; Hyun, Karice; Chew, Derek; Amerena, John; Farouque, Omar; MacIsaac, Andrew; Goodman, Shaun; Yan, Andrew; Aliprandi Costa, Bernadette; Dabin, Bilyana; D'Sousa, Mario Journal: International journal of cardiology Issue: Volume 222(2016) Page Start: 86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and Safety of Tenapanor in Patients With Constipation Predominant Irritable Bowel Syndrome: A 12‐week, Double‐Blind, Placebo‐Controlled, Randomized Phase 3 Trial: 421. (October 2017) Authors: Chey, William D.; Lembo, Anthony J.; Korner, Paul; Yan, Andrew; Rosenbaum, David P. Journal: American journal of gastroenterology Issue: Volume 112(2017)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The relationship between the proportion of admitted high risk ACS patients and hospital delivery of evidence based care. (1st November 2016) Authors: Brieger, David; Hyun, Karice; Chew, Derek; Amerena, John; Farouque, Omar; MacIsaac, Andrew; Goodman, Shaun; Yan, Andrew; Aliprandi Costa, Bernadette; Dabin, Bilyana; D'Sousa, Mario Journal: International journal of cardiology Issue: Volume 222(2016) Page Start: 86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗